Cravath Publishes Winter 2026 Issue of Alumni Journal
Cravath represented Credit Suisse as dealer manager in DJO Finance LLC and DJO Finance Corporation’s US$300 million Reg D exchange offer with the holders of their senior subordinated notes for new third‑lien notes. Cravath also represented the initial purchasers, led by Credit Suisse, in connection with the US$1.02 billion 144A/Reg. S high‑yield debt offering of second‑lien notes of DJO Finco Inc., a subsidiary that was merged into DJO Finance LLC. Finally, Cravath represented Macquarie Capital in connection with a new US$1.055 billion first‑priority term loan agreement with DJO Finance LLC and DJO Finance Corporation. All these transactions were coordinated with a new ABL facility as part of a complete recapitalization of the outstanding debt of DJO.
DJO Finance LLC is a global developer, manufacturer and distributor of high‑quality medical devices that provide solutions for musculoskeletal health, vascular health and pain management. DJO Finance LLC is a portfolio company of private equity sponsor Blackstone Group, L.P. All the transactions closed on May 7, 2015. Proceeds of the offering and the term loans were used to refinance outstanding debt of DJO.
The Cravath team included partner Kris F. Heinzelman and associates Raffael M. Fiumara, Matthew G. Jones, William F. Roegge and Hyatt M. Howard on securities matters and partner Paul H. Zumbro, senior attorney Sarah F. Rosen and associates Ryan M. Farha and Caitlin M. Hyduke on banking matters. Sean M. Gholz also worked on securities matters.
Deals & Cases
February 20, 2026
Cravath represented First Solar, Inc. in connection with its $1.5 billion revolving credit facility. First Solar is America’s leading photovoltaic solar technology and manufacturing company, and the only US‑headquartered company among the world’s largest solar manufacturers. The transaction closed on February 13, 2026.
Deals & Cases
January 08, 2026
Cravath represented the administrative agent, joint lead arrangers and joint bookrunners in connection with $3.5 billion of credit facilities made available to Genmab, a leading international biotechnology company, and one of its wholly‑owned subsidiaries, Genmab Finance LLC, as part of the financing transactions undertaken in connection with its acquisition of Merus N.V., a leading oncology company developing innovative antibody therapeutics. The credit facilities consisted of a $2 billion term loan “B” facility, a $1 billion term loan “A” facility and a $500 million revolving credit facility. The transaction closed on December 12, 2025.
Deals & Cases
December 24, 2025
Cravath represented the administrative agent, joint lead arranger and joint bookrunner in connection with $3.2 billion of revolving credit facilities made available to Ameren Corporation and Union Electric Company (the “Missouri Borrowers”) and Ameren Corporation and Ameren Illinois Company (the “Illinois Borrowers”). Ameren Corporation is an American power company that engages in the rate‑regulated electric generation, transmission and distribution activities; and rate‑regulated natural gas distribution and transmission businesses. The facilities consisted of a $1.9 billion revolving credit facility (Missouri Borrowers) and $1.3 billion revolving credit facility (Illinois Borrowers). The transaction closed on December 10, 2025.
Deals & Cases
November 24, 2025
Cravath represented the administrative agent, joint lead arranger and joint bookrunner in connection with a $2 billion revolving credit facility made available to Thomson Reuters Corporation, a leading AI and technology company empowering professionals with trusted content and workflow automation. The transaction closed on November 10, 2025.
Celebrating 200 years of partnership. In 2019, we celebrated our bicentennial. Our history mirrors that of our nation. Integral to our story is our culture.
Attorney Advertising. ©2026 Cravath, Swaine & Moore LLP.